Search bioRxiv⌕ Search

Biology subjects

Swami, P.

Publications and source records attributed to Swami, P..

2 recordsLinked to original sources

Mapping 3D tissue orientation with tensor-augmented light-sheet microscopy

Mapping the three-dimensional directional organization of biological tissues is essential for understanding their structure and function. However, existing methods cannot resolve micrometer-scale orientation in volumetric samples. We introduce tensor light-sheet scattering microscopy (tLSSM), a label-free method that reconstructs 3D fiber orientations at micrometer resolution in optically cleared tissues, enabling whole-organ imaging. We discovered that even in transparent samples, organized structures such as neural fibers scatter light in directional patterns, consistent with models of light scattering by cylinders. We compared tLSSM against diffusion MRI in the mouse brain, demonstrating strong agreement and orders of magnitude superior spatial resolution. Furthermore, we showcase tLSSMs versatility across diverse contexts, including whole-brain label-free tracing, pathological demyelination lesions, heart tissue, peripheral nerves, and human white matter. By enabling whole-organ fiber orientation mapping compatible with standard light-sheet microscopes, tLSSM establishes a new standard for mesoscopic connectivity studies by mapping tissue architecture beyond the limits of traditional sectioning.

neuroscience↗

Impedance-based assay for pan-cancer early and rapid detection of cell-free DNA

Aberrant DNA methylation is a hallmark of cancer, and plasma cell-free DNA (cfDNA) containing these abnormal methylation patterns has emerged as a promising non-invasive biomarker for pan-cancer detection. However, intrinsic challenges remain that continue to limit its broad clinical application. Here we show a simple and rapid impedance biosensor called Asima Rev that can detect cancer cfDNA in under 5 min without the need for any molecular labelling, electrode modification, signal amplification, or target enrichment steps. Using 216 clinical samples (50 healthy) from 15 different cancer types (all stages) we show an overall sensitivity and specificity of 96.4% and 94.0%, respectively. Differences in methylation content between cancerous and healthy cfDNA lead to distinct solvation behaviour and electro-physicochemical property that remain consistent across cancer types regardless of the distribution patterns of methyl cytosine. Our test exploits this inherent difference.

biophysics↗